[EN] HEPATITIS C INHIBITING COMPOUNDS<br/>[FR] COMPOSES D'INHIBITION DE L'HEPATITE C
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2004101605A1
公开(公告)日:2004-11-25
Compounds of formula (I) wherein B, X, R3, R21, R22, R1 and Rc are defined herein. The compounds are useful as inhibitors of HCV NS3 protease.
Hepatitis C inhibitor compound
申请人:Boehringer Ingelheim International GmbH
公开号:US20040229818A1
公开(公告)日:2004-11-18
Compounds of formula (I):
1
wherein B, X, R
3
, R
21
, R
22
, R
1
and R
c
are defined herein. The compounds are useful as inhibitors of HCV NS3 protease.